| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Novartis is making significant strides in product and service development, particularly in the realm of drug efficacy for kidney diseases, cancer, and autoimmune conditions. Their late-stage clinical trial results for innovative therapies, such as Vanrafia for IgA nephropathy and remibrutinib for chronic urticaria, underscore their commitment to addressing unmet medical needs and advancing treatment options. Furthermore, the introduction of novel therapeutic approaches demonstrates their focus on tackling complex diseases. Overall, the landscape is positive, with strong sentiment driven by promising clinical outcomes. |
| The price action of Novartis AG (NVS) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 2.6 is extremely bullish. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. NVS is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.7, and the negative at -0.8 on 2026-02-18. The forces of Sentiment towards Fundamentals (4), Stock Price Trend (2.6), Option Sentiment (1.5), Valuation Sentiment (1.4), and Sector Price Trend (1.1) will drive up the price. The forces of Price Level Sentiment (-0.5), and Market Risk Appetite (-4.1) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| NVS | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | 0%(0%) | 165.38 | 3.91% | 94 | -0.5% | 0.95% | 2.6 | 0 | 1% | 0.9 | Long | 55% | 4 | -1 |
| 2026-02-17 | 0%(0%) | 166.22 | 3.78% | 103 | 1.91% | 0.96% | 2.9 | 0 | 1% | 1.1 | Long | 70% | 3.5 | -1 |
| 2026-02-16 | 0%(0%) | 2.5 | 0 | 0.3 | 3.7 | -1 | ||||||||
| 2026-02-15 | 0%(0%) | 2.5 | 0 | 0.2 | 4.1 | -1 | ||||||||
| 2026-02-14 | 0%(0%) | 2.5 | 0 | 0.1 | 3.3 | -1 | ||||||||
| 2026-02-13 | 0%(0%) | 163.1 | 3.53% | 99 | 1.19% | 0.97% | 2.5 | 0 | 1% | 0.2 | Long | 70% | 2.9 | -1 |
| 2026-02-12 | 0%(0%) | 161.18 | 3.36% | 98 | 0.7% | 0.78% | 2.3 | 0 | 1% | 0.2 | Long | 70% | 1.8 | -1 |
| 2026-02-11 | 0%(0%) | 160.06 | 3.09% | 101 | 1.18% | 0.79% | 2.3 | 0 | 1% | 0.2 | Long | 70% | 2.4 | -1 |
| 2026-02-10 | 0%(0%) | 158.2 | 2.98% | 98 | 0.73% | 0.39% | 2 | 0 | 1% | -0 | Long | 70% | 1.1 | -1 |
| 2026-02-09 | 0%(0%) | 157.05 | 2.85% | 99 | 0.4% | 0.53% | 1.8 | 0 | 1% | -0.2 | Long | 70% | 0.6 | -1 |
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| 2026-02-18 17:15:38 Successful completion of pivotal trial phases suggests that Novartis is navigating regulatory pathways effectively, which is crucial for the advancement of new therapies to market. |
| 2026-02-18 17:15:38 The introduction of macrocyclic peptide-based therapies indicates a shift towards innovative approaches in treating complex diseases, showcasing Novartis's commitment to addressing previously undruggable targets. |
| 2026-02-18 17:15:38 Fluctuations in Novartis's stock price, such as a slight decrease of 0.5%, reflect ongoing market reactions to company developments and external economic factors. |
| 2026-02-18 17:15:38 Positive results from Novartis's Phase III trial for remibrutinib showcase significant advancements in treatment options for chronic inducible urticaria, addressing unmet medical needs. |
| 2026-02-18 17:15:38 The collaboration between Unnatural Products and Novartis indicates a strong trend in pharmaceutical partnerships aimed at developing new therapies, particularly in the cardiovascular space. |